Literature DB >> 7072798

Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol.

F T Fraunfelder, G C Bagby, D J Kelly.   

Abstract

A 73-year-old woman died of aplastic anemia less than two months after undergoing cataract extraction and beginning topical therapy with chloramphenicol. The first signs of pancytopenia began within one month of the surgery. The pattern of the aplastic anemia was associated with an idiosyncratic response to chloramphenicol. This was the second report of fatal aplastic anemia after topical treatment with chloramphenicol for ocular conditions, although two cases of reversible bone marrow hypoplasia have also been reported. Any other suspected cases of ocular toxicity associated with topically applied chloramphenicol should be reported to the National Registry of Drug-Induced Ocular Side Effects, Oregon Health Sciences University, Portland, OR 97201.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7072798     DOI: 10.1016/0002-9394(82)90540-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  18 in total

Review 1.  Comparative review of topical ophthalmic antibacterial preparations.

Authors:  P Y Robert; J P Adenis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Is it time to stop using chloramphenicol on the eye? Fears are based on only six cases.

Authors:  R J Mulla; E Barnes; T R Rogers
Journal:  BMJ       Date:  1995-08-12

3.  Is it time to stop using chloramphenicol on the eye? Safe in patients with no history of blood dyscrasia.

Authors:  R J Buckley; C M Kirkness; J J Kanski; A E Ridgway; A B Tullo; P G Watson
Journal:  BMJ       Date:  1995-08-12

Review 4.  Ocular chloramphenicol and aplastic anaemia. Is there a link?

Authors:  S A Rayner; R J Buckley
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

5.  Possible association between ocular chloramphenicol and aplastic anaemia--the absolute risk is very low.

Authors:  J R Laporte; X Vidal; E Ballarín; L Ibáñez
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

6.  Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis).

Authors:  Preston Howard Blomquist
Journal:  Trans Am Ophthalmol Soc       Date:  2006

7.  Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia?

Authors:  C N McGhee; C N Anastas
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

Review 8.  Systemic and local tolerability of ophthalmic drug formulations. An update.

Authors:  F C Hugues; C Le Jeunne
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

9.  A study to compare the use of fusidic acid viscous eye drops and chloramphenicol eye ointment in an accident and emergency department.

Authors:  M R James; R Brogan; M Carew-McColl
Journal:  Arch Emerg Med       Date:  1991-06

Review 10.  Systemic reactions to ophthalmic drug preparations.

Authors:  F T Fraunfelder; S M Meyer
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.